Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2023

Open Access 01-12-2023 | Influenza | Study Protocol

RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial

Authors: Shuo Yang, Yan-ming Xie, Lian-xin Wang

Published in: BMC Complementary Medicine and Therapies | Issue 1/2023

Login to get access

Abstract

Background

The morbidity of influenza in children increased rapidly in decade. Reduning injection (RDN), a small but fine Chinese herbal formula, has antipyretic, antiviral, anti-inflammatory effects. We intend to evaluate the efficacy and safety of RDN for the influenza in children versus Oseltamivir, explore the possible antiviral mechanism of RDN and provide evidence-based medical evidence for rational clinical drug usage.

Method

We design a randomized, double-blind, double-dummy, parallel control of positive drug, multi-centre clinical study. According to the formula of mean superiority test, a total of 240 patients with influenza in children will be randomized 1:1 into the experimental group and control group. The experimental group will take RDN and Oseltamivir phosphate granule simulants and the control group will take Oseltamivir phosphate granule and RDN simulants. Each group will be treated for 5 days. The primary outcome measure is temperature recovery time, and the secondary outcome measures include time when the fever begins to subside, time and degree of disease to alleviate, disappearance rate of individual symptoms and so on. We will measure before enrollment and each 24 h after treatment for comparison.

Discussion

The study is launched to evaluate the efficacy and safety of RDN for the treatment of influenza in children and to provide an alternative option for influenza in children.

Trial registration

This study is registered in ClinicalTrials.gov as NCT04183725, registered on 3 December, 2019.
Appendix
Available only for authorised users
Literature
3.
go back to reference Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. Am Fam Physician. 2019(100):751–8. PMID: 31845781. Gaitonde DY, Moore FC, Morgan MK. Influenza: diagnosis and treatment. Am Fam Physician. 2019(100):751–8. PMID: 31845781.
23.
go back to reference Lyu J, Xie YM, Gao Z, et al. Sanjin tablets for acute uncomplicated lower urinary tract infection (syndrome of dampness-heat in the lower jiao): protocol for randomized, double-blind, double-dummy, parallel control of positive drug, multicenter clinical trial. Trials. 2019;20446. https://doi.org/10.1186/s13063-019-3539-5. Lyu J, Xie YM, Gao Z, et al. Sanjin tablets for acute uncomplicated lower urinary tract infection (syndrome of dampness-heat in the lower jiao): protocol for randomized, double-blind, double-dummy, parallel control of positive drug, multicenter clinical trial. Trials. 2019;20446. https://​doi.​org/​10.​1186/​s13063-019-3539-5.
26.
go back to reference Hu S, Ma R, Shen K, et al. Efficacy and safety of Qinxiang Qingjie oral solution for the treatment of influenza in children: a randomized, double-blind, multicenter clinical trial. Transl Pediatr. 2022;11987–1000. https://doi.org/10.21037/tp-22-201. Hu S, Ma R, Shen K, et al. Efficacy and safety of Qinxiang Qingjie oral solution for the treatment of influenza in children: a randomized, double-blind, multicenter clinical trial. Transl Pediatr. 2022;11987–1000. https://​doi.​org/​10.​21037/​tp-22-201.
Metadata
Title
RDN for the treatment of influenza in children: a randomized, double-blinded, parallel-controlled clinical trial
Authors
Shuo Yang
Yan-ming Xie
Lian-xin Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2023
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-023-04037-1

Other articles of this Issue 1/2023

BMC Complementary Medicine and Therapies 1/2023 Go to the issue